The cancer pain management market was valued at USD 6 billion in 2024 and is estimated at USD 6.27 billion in 2025. Polaris Market Research projects the market to reach USD 9.3 billion by 2034, growing at a CAGR of 4.50% during the forecast period 2025–2034. Growth is fueled by rising cancer incidence and the need for effective palliative care solutions. Key players include BioDelivery...